Background illustration for clinical trials search

Paid Clinical Trials Ann Arbor

Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,743

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

for

Advanced Lung Non-Small Cell Carcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03191149

Phase2, Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for

Intracranial Meningioma, Recurrent Meningioma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase2, Recruiting

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

for

Castration-Resistant Prostate Carcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT06470243

Phase3, Recruiting

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

for

Colorectal Cancer, Sarcopenia

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 60+

Code: NCT03998202

Recruiting

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

for

Malignancy

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

for

Mantle Cell Lymphoma

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 60+

Code: NCT05976763

Phase3, Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

for

Locally Advanced Lung Non-Small Cell Carcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Chelsea MI, Livonia MI,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05624996

Phase3, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase2, Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for

Renal Pelvis and Ureter Urothelial Carcinoma

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase2, Phase3, Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

for

Metastatic Colorectal Adenocarcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05673148

Phase2, Recruiting

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

for

Advanced Lung Non-Small Cell Carcinoma,

Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 70+

Code: NCT06096844

Phase3, Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for

Metastatic Head and Neck Squamous Cell Carcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for

Advanced Lung Non-Squamous Non-Small Cell Carcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for

Lung Non-Small Cell Carcinoma

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase2, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for

Malignant Female Reproductive System Neoplasm,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase2, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for

Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,

Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for

Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis

Location: Ypsilanti MI, Royal Oak MI, Lansing MI, Saginaw MI,

Sponsor: University of British Columbia

Sex: All

Age: 0+

Code: NCT04634240

Recruiting

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

for

Extensive Stage Small Cell Lung Cancer

Location: Ann Arbor MI, Chicago IL, Sioux Falls SD, Houston TX,

Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06598306

Phase1, Recruiting

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for

Crohn Disease, Colitis, Ulcerative

Location: Ypsilanti MI, Charlottesville VA, New York NY,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0+

Code: NCT06651281

Phase3, Recruiting

Paid Clinical Trials Ann Arbor

Filter results

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Interested in new trials?

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)